Devonian Health Group Stock Debt To Equity
| GSD Stock | CAD 0.20 0.02 9.09% |
Devonian Health Group fundamentals help investors to digest information that contributes to Devonian Health's financial success or failures. It also enables traders to predict the movement of Devonian Stock. The fundamental analysis module provides a way to measure Devonian Health's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Devonian Health stock.
Devonian | Debt To Equity |
Devonian Health Group Company Debt To Equity Analysis
Devonian Health's Debt to Equity is calculated by dividing the Total Debt of a company by its Equity. If the debt exceeds equity of a company, then the creditors have more stakes in a firm than the stockholders. In other words, Debt to Equity ratio provides analysts with insights about composition of both equity and debt, and its influence on the valuation of the company.
Current Devonian Health Debt To Equity | 43.00 % |
Most of Devonian Health's fundamental indicators, such as Debt To Equity, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Devonian Health Group is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
High Debt to Equity ratio typically indicates that a firm has been borrowing aggressively to finance its growth and as a result may experience a burden of additional interest expense. This may reduce earnings or future growth. On the other hand a small D/E ratio may indicate that a company is not taking enough advantage from financial leverage. Debt to Equity ratio measures how the company is leveraging borrowing against the capital invested by the owners.
| Competition |
Devonian Total Stockholder Equity
Total Stockholder Equity |
|
According to the company disclosure, Devonian Health Group has a Debt To Equity of 43.0%. This is 19.69% lower than that of the Biotechnology sector and 122.11% higher than that of the Health Care industry. The debt to equity for all Canada stocks is 11.7% higher than that of the company.
Devonian Debt To Equity Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Devonian Health's direct or indirect competition against its Debt To Equity to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Devonian Health could also be used in its relative valuation, which is a method of valuing Devonian Health by comparing valuation metrics of similar companies.Devonian Health is currently under evaluation in debt to equity category among its peers.
Devonian Fundamentals
| Return On Equity | -0.23 | ||||
| Return On Asset | -0.0812 | ||||
| Profit Margin | (0.33) % | ||||
| Operating Margin | (0.06) % | ||||
| Current Valuation | 22.03 M | ||||
| Shares Outstanding | 148.22 M | ||||
| Shares Owned By Insiders | 14.20 % | ||||
| Number Of Shares Shorted | 6.79 K | ||||
| Price To Book | 2.05 X | ||||
| Price To Sales | 3.04 X | ||||
| Revenue | 2.35 M | ||||
| Gross Profit | 561.01 K | ||||
| EBITDA | (2.46 M) | ||||
| Net Income | (4.6 M) | ||||
| Cash And Equivalents | 413.87 K | ||||
| Cash Per Share | 0.01 X | ||||
| Total Debt | 3.58 M | ||||
| Debt To Equity | 43.00 % | ||||
| Current Ratio | 0.95 X | ||||
| Book Value Per Share | 0.09 X | ||||
| Cash Flow From Operations | (4.36 M) | ||||
| Short Ratio | 1.66 X | ||||
| Earnings Per Share | (0.01) X | ||||
| Beta | 1.22 | ||||
| Market Capitalization | 29.64 M | ||||
| Total Asset | 19.18 M | ||||
| Retained Earnings | (25.43 M) | ||||
| Working Capital | 1.49 M | ||||
| Net Asset | 19.18 M |
About Devonian Health Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Devonian Health Group's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Devonian Health using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Devonian Health Group based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Devonian Stock Analysis
When running Devonian Health's price analysis, check to measure Devonian Health's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Devonian Health is operating at the current time. Most of Devonian Health's value examination focuses on studying past and present price action to predict the probability of Devonian Health's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Devonian Health's price. Additionally, you may evaluate how the addition of Devonian Health to your portfolios can decrease your overall portfolio volatility.